Gynecologic Oncology Group [clinicaltrials_resource:e6134c14d3f729308d0216cf826a8ee4]
Laparoscopic Surgery or Standard Surgery in Treating Patients With Endometrial Cancer or Cancer of the Uterus [clinicaltrials:NCT00002706]Methotrexate Compared With Dactinomycin in Treating Patients With Gestational Trophoblastic Neoplasia [clinicaltrials:NCT00003702]Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Stage III or Stage IV Endometrial Cancer [clinicaltrials:NCT00005830]Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Stage III or Stage IV Endometrial Cancer [clinicaltrials:NCT00005840]clinicaltrials:NCT00006011Trastuzumab in Treating Patients With Stage III, Stage IV, or Recurrent Endometrial Cancer [clinicaltrials:NCT00006089]Combination Chemotherapy in Treating Patients With Stage III or Stage IV Ovarian Epithelial Cancer or Primary Peritoneal Cancer [clinicaltrials:NCT00011986]clinicaltrials:NCT00022659clinicaltrials:NCT00023712clinicaltrials:NCT00025155Thalidomide in Treating Patients With Recurrent or Persistent Cancer of the Uterus [clinicaltrials:NCT00025220]clinicaltrials:NCT00025233Thalidomide in Treating Patients With Recurrent or Persistent Endometrial Cancer [clinicaltrials:NCT00025467]clinicaltrials:NCT00025506Gefitinib in Treating Patients With Persistent or Recurrent Endometrial Cancer [clinicaltrials:NCT00027690]Combination Chemotherapy and Filgrastim or Pegfilgrastim in Treating Patients With Recurrent or Persistent Cancer of the Uterus [clinicaltrials:NCT00031629]Erlotinib in Treating Patients With Persistent or Recurrent Cancer of the Cervix [clinicaltrials:NCT00031993]Imatinib Mesylate in Treating Patients With Persistent or Recurrent Ovarian Epithelial or Primary Peritoneal Cancer [clinicaltrials:NCT00041041]clinicaltrials:NCT00041080CT-2103 in Treating Patients With Recurrent or Persistent Ovarian Epithelial Cancer or Primary Peritoneal Cancer [clinicaltrials:NCT00045682]Research Study in Patients With Advanced Ovarian Epithelial Cancer [clinicaltrials:NCT00053235]clinicaltrials:NCT00053365Vaccine Therapy in Preventing Cervical Cancer in Patients With Cervical Intraepithelial Neoplasia [clinicaltrials:NCT00054041]Polyglutamate Paclitaxel and Carboplatin in Treating Patients With Ovarian Epithelial, Peritoneal, or Fallopian Tube Cancer [clinicaltrials:NCT00060359]Comparison of Four Combination Chemotherapy Regimens Using Cisplatin in Treating Patients With Stage IVB, Recurrent, or Persistent Cancer of the Cervix [clinicaltrials:NCT00064077]Radiation Therapy Plus Cisplatin and Gemcitabine in Treating Patients With Cervical Cancer [clinicaltrials:NCT00068549]Lymph Node Mapping and Sentinel Lymph Node Identification in Patients With Stage IB1 Cervical Cancer [clinicaltrials:NCT00070317]clinicaltrials:NCT000754003-AP and Cisplatin in Treating Patients With Recurrent or Persistent Platinum-Resistant Ovarian Epithelial or Primary Peritoneal Cancer [clinicaltrials:NCT00081276]Sorafenib in Treating Patients With Persistent or Recurrent Ovarian Epithelial or Peritoneal Cancer [clinicaltrials:NCT00093626]clinicaltrials:NCT00095979Lapatinib in Treating Patients With Recurrent or Persistent Endometrial Cancer [clinicaltrials:NCT00096447]clinicaltrials:NCT00113373Gemcitabine and Docetaxel in Treating Patients With Recurrent or Persistent Uterine Cancer [clinicaltrials:NCT00114218]Vorinostat in Treating Patients With Recurrent or Persistent Ovarian Epithelial or Primary Peritoneal Cavity Cancer [clinicaltrials:NCT00132067]clinicaltrials:NCT00301964Sunitinib in Treating Patients With Recurrent or Persistent Leiomyosarcoma of the Uterus [clinicaltrials:NCT00378911]clinicaltrials:NCT00429793Oregovomab With or Without Cyclophosphamide in Treating Patients With Stage III or Stage IV Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer That Responded to Second-Line Chemotherapy [clinicaltrials:NCT00551265]Flexitouch® Home Maintenance Therapy or Standard Home Maintenance Therapy in Treating Patients With Lower-Extremity Lymphedema Caused by Treatment for Cervical Cancer, Vulvar Cancer, or Endometrial Cancer [clinicaltrials:NCT00577317]
location [clinicaltrials_vocabulary:location]
Gynecologic Oncology Group [clinicaltrials_resource:e6134c14d3f729308d0216cf826a8ee4]
Bio2RDF identifier
e6134c14d3f729308d0216cf826a8ee4
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:e6134c14d3f729308d0216cf826a8ee4
address [clinicaltrials_vocabulary:address]
identifier
clinicaltrials_resource:e6134c14d3f729308d0216cf826a8ee4
title
Gynecologic Oncology Group
@en
type
label
Gynecologic Oncology Group [clinicaltrials_resource:e6134c14d3f729308d0216cf826a8ee4]
@en